CAMP
CAMP4 THERAPEUTICS CORPORATION
NASDAQ: CAMP · HEALTHCARE · BIOTECHNOLOGY
$4.01
-6.09% today
Updated 2026-04-29
Market cap
$230.55M
P/E ratio
—
P/S ratio
65.91x
EPS (TTM)
$-2.65
Dividend yield
—
52W range
$1 – $8
Volume
0.2M
CAMP4 THERAPEUTICS CORPORATION (CAMP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-3,671.00%
ROE
-145.10%
ROA
-33.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $222.34M | $-31.19M | 22.22% | -13.03% | -14.03% |
| 2007 | $140.91M | $-84.15M | 13.13% | -71.55% | -59.72% |
| 2008 | $98.37M | $-49.66M | 38.76% | -45.73% | -50.49% |
| 2009 | $112.11M | $-10.85M | 19.97% | -8.91% | -9.68% |
| 2010 | $114.33M | $-3.28M | 25.85% | -1.80% | -2.87% |
| 2011 | $138.73M | $5.22M | 30.29% | 5.31% | 3.76% |
| 2012 | $180.58M | $44.63M | 31.51% | 8.85% | 24.71% |
| 2013 | $235.90M | $11.80M | 33.88% | 7.78% | 5.00% |
| 2014 | $250.61M | $16.51M | 34.88% | 9.95% | 6.59% |
| 2015 | $280.72M | $16.94M | 36.68% | 10.00% | 6.03% |
| 2016 | $351.10M | $-7.15M | 40.83% | 0.38% | -2.04% |
| 2017 | $365.91M | $16.62M | 41.24% | 2.17% | 4.54% |
| 2018 | $363.80M | $18.40M | 40.62% | 5.41% | 5.06% |
| 2019 | $366.11M | $-78.77M | 39.14% | -4.58% | -21.52% |
| 2020 | $308.59M | $-21.16M | 39.67% | -1.25% | -6.86% |
| 2021 | $295.84M | $-31.15M | 41.20% | -5.18% | -10.53% |
| 2022 | $294.95M | $-44.19M | 36.96% | -15.26% | -14.98% |
| 2023 | $350000.00 | $-49.29M | 100.00% | -14,822.57% | -14,083.14% |
| 2024 | $652000.00 | $-51.79M | 100.00% | -8,142.33% | -7,943.40% |
| 2025 | $3.50M | $-80.40M | 53.14% | -1,488.31% | -2,298.54% |